Windtree Therapeutics, a publicly-listed company, has pivoted its focus into a digital treasury, analyzing distressed firms and discussing potential large Ethereum acquisitions.
3 reports, 2 independent
Updated Aug 21
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Windtree Therapeutics, a publicly-listed company, has pivoted its focus into a digital treasury, analyzing distressed firms and discussing potential large Ethereum acquisitions.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Windtree Therapeutics pivots into a digital treasury focused on BNB, while also eyeing large ETH acquisitions.1 source
Windtree, Nano Labs, and CEA Industries are establishing BNB treasuries.1 source
Wintree and other firms added BNB to their treasuries, amid pressure on the asset.1 source
Keep exploring
The entities involved
-
Windtree Therapeutics (United States)
company in Philadelphia, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- decryptNasdaq Boots Windtree a Month After $700M BNB Treasury Pivot Fails to Lift Stock Windtree Therapeutics, a Pennsylvania-based drug developer, is being delisted from Nasdaq, just over a month after its
- CoinDeskBNB Climbs Above $810 as Buyers Target $815 Resistance The price of BNB climbed more than 1.5% in the last 24 hours, managing to overcome weakness during the session to move above the $810 mark, up f
- CoinDeskBNB Climbs Toward $760 as Market Sell-Off Eases BNB saw a slight rise over the last 24-hour period, but has been recovering steadily after seeing a large drawdown to test its $750 support level. The